combined vaccine adjuvants (ImmuRx)

N/A

Report date: 2025/03/18 18:19:38

Base Information

Drug Namecombined vaccine adjuvants (ImmuRx)
Drug Alias NameCD40 agonist/IFN-apha 2b vaccine adjuvants (ImmuRx)CD40/TLR agonist vaccine adjuvants (ImmuRx)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInterferon alpha 2 ligandToll-like receptor agonistsTumor necrosis factor receptor superfamily member 5 agonists
TargetsInterferon alpha-2Toll-like receptorTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmuRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmuRx Inc
Inactive CompaniesN/A
Active IndicationsVaccination
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A